Screener
Mirum Pharmaceuticals, Inc. MIRM Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies | ||
| Stockholders’ (deficit) equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 64,754,699 and 51,896,391 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 6 | 5 |
| Additional paid-in capital | 1,515,172 | 981,878 |
| Accumulated deficit | (1,524,926) | (667,544) |
| Accumulated other comprehensive (loss) income | (674) | 351 |
| Total stockholders’ (deficit) equity | (10,422) | 314,690 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s common stock?
- Mirum Pharmaceuticals, Inc. (MIRM) reported common stock of 200M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s common stock has grown at a 822.1% compound annual growth rate (CAGR), from 3K to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Mirum Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude